These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 23237886)
21. Rare disease registries: a call to action. Lacaze P; Millis N; Fookes M; Zurynski Y; Jaffe A; Bellgard M; Winship I; McNeil J; Bittles AH Intern Med J; 2017 Sep; 47(9):1075-1079. PubMed ID: 28891182 [TBL] [Abstract][Full Text] [Related]
22. [University center on rare diseases, as a successful example of the integration of the clinical sector into the system of medical education]. Vadachkoriia ZO; Abesadze GG; Pagava KI; Korinteli IA Georgian Med News; 2011 Apr; (193):20-2. PubMed ID: 21617268 [TBL] [Abstract][Full Text] [Related]
23. The European Union Committee of Experts on Rare Diseases: three productive years at the service of the rare disease community. Aymé S; Rodwell C Orphanet J Rare Dis; 2014 Feb; 9():30. PubMed ID: 24580800 [TBL] [Abstract][Full Text] [Related]
24. [Rare pulmonary diseases: from the adoption of orphan diseases to structured healthcare networks]. Cottin V; Cordier JF Rev Mal Respir; 2014 Dec; 31(10):889-92. PubMed ID: 25465349 [No Abstract] [Full Text] [Related]
25. A unifying strategy for clinical trials in rare urological malignancy. Nicholson S Nat Clin Pract Urol; 2008 Dec; 5(12):652-3. PubMed ID: 19015645 [No Abstract] [Full Text] [Related]
27. The current situation and needs of rare disease registries in Europe. Taruscio D; Gainotti S; Mollo E; Vittozzi L; Bianchi F; Ensini M; Posada M Public Health Genomics; 2013; 16(6):288-98. PubMed ID: 24503589 [TBL] [Abstract][Full Text] [Related]
28. National Registry of Designated Intractable Diseases in Japan: Present Status and Future Prospects. Kanatani Y; Tomita N; Sato Y; Eto A; Omoe H; Mizushima H Neurol Med Chir (Tokyo); 2017 Jan; 57(1):1-7. PubMed ID: 27666154 [TBL] [Abstract][Full Text] [Related]
29. Pediatric pancreatic tumors: the orphan looking for a home. Brennan B Pediatr Blood Cancer; 2010 May; 54(5):659-60. PubMed ID: 20063425 [No Abstract] [Full Text] [Related]
30. Focusing on rare diseases in China: are we there yet? Yang L; Su C; Lee AM; Bai HX Orphanet J Rare Dis; 2015 Nov; 10():142. PubMed ID: 26525984 [TBL] [Abstract][Full Text] [Related]
31. Management options for rare diseases in children and adolescents in Georgia (experience of the country with transitional economy). Pagava K; Abesadze G; Uberi N; Korinteli I; Paghava I; Kvezereli-Kopadze M; Parulava T; Korinteli M; Kiseliova T Georgian Med News; 2011 Apr; (193):8-11. PubMed ID: 21617265 [TBL] [Abstract][Full Text] [Related]
32. CEMARA: a Web dynamic application within a N-tier architecture for rare diseases. Messiaen C; Le Mignot L; Rath A; Richard JB; Dufour E; Ben Said M; Jais JP; Verloes A; Le Merrer M; Bodemer C; Baujat G; Gerard-Blanluet M; Bourdon-Lanoy E; Salomon R; Ayme S; Landais P Stud Health Technol Inform; 2008; 136():51-6. PubMed ID: 18487707 [TBL] [Abstract][Full Text] [Related]
33. Commentary on rare dyslipidaemia paper. Stock JK Atherosclerosis; 2020 Feb; 295():54-58. PubMed ID: 31952820 [No Abstract] [Full Text] [Related]
35. [Rare diseases in pulmonary medicine and its challenges]. Wencker M; Teschler H; Vogelmeier C; Koczulla R Pneumologie; 2012 Jul; 66(7):437-41. PubMed ID: 22692970 [TBL] [Abstract][Full Text] [Related]
36. [Understanding the diagnostic delay in rare diseases]. Deden AC; Alma MA; Van Zelst-Stam WAG Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32395952 [TBL] [Abstract][Full Text] [Related]